Gregory Lucier - Invuity Insider

IVTY -- USA Stock  

USD 3.45  0.10  2.82%

Chairman of the Board

Mr. Gregory T. Lucier was appointed as Chairman of the Board of the Company., effective December 31, 2015. Mr. Lucier has served as a member of our board of directors since October 2014 and as the Chairman of our board of directors since December 2015. Since May 2015, Mr. Lucier has served as the Chief Executive Officer of NuVasive, a publicly traded medical device company. From November 2008 to February 2014, Mr. Lucier was Chairman of the board of directors and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. In May 2003, Mr. Lucier joined Life Technologies predecessor company, Invitrogen Corporationrationration, as Chief Executive Officer. Prior to Life Technologies, Mr. Lucier was a corporate officer at General Electric Company from 1994 to 2003 where he served in a variety of leadership roles. Mr. Lucier serves on the board of directors of NuVasive and Catalent, Inc
Age: 52  Chairman Since 2015  MBA    
Lucier received a B.S. with honors in industrial engineering from Pennsylvania State University and an M.B.A. from Harvard Business School. We believe Mr. Lucier is qualified to serve as a member of our board of directors because of his management and operational experience in the healthcare industry.

Gregory Lucier Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (37.87) % which means that it has lost $37.87 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (237.71) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.98 M in liabilities with Debt to Equity (D/E) ratio of 641.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity has Current Ratio of 2.5 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets. It employs 161 people.Invuity (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 161 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.

Invuity Leadership Team

Robert Gerberich, President
Douglas Heigel, VP
Daniel Wolterman, Director
Alex Vayser, Founder
William Burke, Director, MBA
Philip Sawyer, CEO, MBA
Eric Roberts, Director
Andrew Sale, President
Scott Flora, Director
Gregory Brown, Executive, MBA
James Mackaness, CFO
Steve Annen, President
Joseph Guido, President, MBA
Randall Lipps, Director
Paul Davison, VP
Reza Zadno, Director, Ph.D
Brett Robertson, Executive
Gregory Lucier, Chairman, MBA
Marcia Fish, Executive, MBA

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Portfolio Suggestion

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.